Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind, Multicenter, Active Controlled Parallel Group Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA

NCT00652925 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00652925
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00652925 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind, Multicenter, Active Controlled Parallel Group Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2002
Completion date
April 30, 2005
Enrollment
225 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, juvenile rheumatoid